PROCEPT BioRobotics is bettering the lives of men by developing robotic surgical solutions to treat prostate disease. The AquaBeam System delivers Aquablation therapy, precise tissue resection with intelligent waterjet robotics for the treatment of BPH. The AquaBeam System utilizes intra-procedural ultrasound imaging to enable real-time surgical planning and mapping of the prostate, followed by robotically controlled Aquablation of the defined resection area, which is designed to offer predictable and reproducible outcomes, independent of prostate size and shape. The AquaBeam System has CE Mark approval and is available for investigational use only in the United States.
Brands: AQUABEAM® system for Aquablation Therapy